Clinical Trials
Braintumor Website

There are 3 trials:
Facility: Central Texas Neurology Consultants
NCT Trial Name# of Centers

NCT02637856

  A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
84

NCT02073279

  Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD
59

NCT02241785

  Natalizumab (BG00002) as an Efficacy Switch in Subjects With Relapsing Multiple Sclerosis (MS) After Failure on Other Therapies
8



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites